BTK-IN-28

• Target:

  BTK

• Related Pathways:

  Tyrosine Kinase/Adaptors|||Angiogenesis

• Bioactivity:

  BTK-IN-28 (compound PID-4) is a potent BTK inhibitor with anti-cancer properties. It effectively inhibits BTK and downstream signaling cascades, selectively suppressing the proliferation of Burkitt's lymphoma RAMOS cells, while exhibiting no significant cytotoxicity towards non-tumor cells.

• Molecular Formula:

  C20H20N2O4S

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C